Speaker Profile

Ph.D., Chief Business Officer, Head of Therapeutics, Mammoth Biosciences

Biography
Peter builds on more than 20 years of pharma and biotech expertise to drive corporate strategy and partnering efforts in his current role. Mammoth is a private company, co-founded by Nobel Laureate Jennifer Doudna, and focuses on next generation CRISPR systems translating into therapeutic and diagnostic applications. Peter joined the company from Casebia Therapeutics which he co-founded as a Joint Venture between Bayer and CRISPR Therapeutics, and which is now fully owned by CRISPR Tx. Prior to Casebia, Peter has been at Bayer Healthcare in various positions in the US and Germany covering commercial, business development and licensing, project management, operations, and R&D within various indication fields. Peter completed postdoctoral studies at Stanford University and holds a Ph.D. in Organic Chemistry from the University of Marburg. He is a co-inventor of more than 45 patents including for the approved drug Letermovir.


 Session Abstract – PMWC 2022 Silicon Valley


Track Chair:
Jane Grogan, Graphite Bio

Sessions:

  • Building Future Precision Care in Qatar
    Session Chair: Khalid Fakhro, Sidra Medicine
    - Barbro Friden, Sidra Medicine
    - Ziyad Hijazi, Sidra Medicine
    - Edison Liu, Jackson Labs
  • Advances in Gene & Cell Therapies
    - Peter Nell, Mammoth
    - Laura Sepp-Lorenzino, Intellia Tx
    - Amy Simon, Beam Therapeutics
    - Eric Ostertag, Poseida Therapuetics
    - Jane Grogan, Graphite Bio
  • Translating CGT to the Clinic
    Session Chair: Nicole K. Paulk, UCSF
    - Matthew Porteus, Stanford
    - Eric Crombez, Ultragenyx Gene Therapy
    - Peter Francis, 4D Molecular Therapeutics
    - Erandi De Silva, Forge Biologics
    - Patrice Hugo, Q2 Solutions
  • Bioethics & Ethical Implications in Cell and Gene Therapies
    Session Chair: Ilana Yurkiewicz, Stanford University
  • Past, Present and Future of CRISPR Where will CRISPR Take Us and How is the Technology Evolving to Realize its Full Potential
    Session Chair: Janice Chen, Mammoth
    - Fyodor Urnov, UC Berkeley
    - Kiana Aran, Cardea Bio
    - Laura Sepp-Lorenzino, Intellia Tx